Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Gemigliptin in Type 2 Diabetes Who Have Inadequate GlycemIc Control With Dapagliflozin and Metformin (SOLUTION Study) [Phase 3]

View source ↗

Summary

Phase 3 trial investigating gemigliptin added to dapagliflozin and metformin in type 2 diabetes patients with inadequate glycemic control; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)
• Gemigliptin (gemigliptin)
• metformin (metformin)

Snippet

Sponsor: LG Chem | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED